Page last updated: 2024-09-02

ecteinascidin 743 and Leukemia, Lymphocytic, Chronic, B-Cell

ecteinascidin 743 has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babu, V; Biersack, B; Bloehdorn, J; Chessa, L; Crispatzu, G; Efremov, DG; Hallek, M; Herling, CD; Herling, M; Knittel, G; Lohmann, G; Mayer, P; Muenzner, JK; Prinz, C; Reinart, N; Reinhardt, HC; Schneider, JI; Schobert, R; Schumacher, B; Stilgenbauer, S; Vasyutina, E1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Leukemia, Lymphocytic, Chronic, B-Cell

ArticleYear
Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia.
    Leukemia, 2017, Volume: 31, Issue:5

    Topics: Animals; Apoptosis; Cell Line, Tumor; Clinical Trials as Topic; Dioxoles; DNA Repair; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Tetrahydroisoquinolines; Trabectedin; Transcription, Genetic; Tumor Cells, Cultured; Vidarabine

2017